Steroid Injection Availability in Hospital Pharmacy
The clinical evidence behind common steroid injection types used in Indian hospitals, and what reliable pharmacy stocking of this category requires.
This covers what the evidence actually supports for the major steroid injection categories a hospital handles, where the evidence is strong versus limited, and what that means for keeping this category reliably in stock.
What does the evidence say about transforaminal epidural steroid injections?
A systematic review found Level 1 evidence supporting transforaminal epidural steroid injections for radicular pain from disc herniation, with significant pain and function improvement at three and six months for both particulate and nonparticulate formulations.
Evidence for other indications is weaker. Central spinal stenosis and failed back surgery syndrome carry only Level IV evidence from single moderate-quality studies, and foraminal stenosis or axial pain relies on opinion-based consensus rather than controlled trial data.
The same review describes transforaminal injections as generally safe, while acknowledging rare but serious complications, including reported cases of spinal cord infarction linked to particulate steroid use, though causation in those cases appears multifactorial rather than attributable to the steroid alone. The review's authors specifically flag technique, an infraneural approach with blunt needles, as offering the greatest safety margin, which places procedural skill alongside drug selection as a genuine safety variable for this category.
How does the evidence for intra-articular joint injections compare?
Intra-articular corticosteroid injections, most often used for knee osteoarthritis, show a different evidence pattern again: modest, short-lived pain relief of roughly two to four weeks in meta-analysis data, alongside cohort evidence linking repeat use to greater meniscal thinning, joint-space narrowing, and a higher subsequent rate of knee arthroplasty. This is a materially different risk-benefit profile from the disc-herniation epidural evidence above, even though both use structurally similar corticosteroid molecules.
The clinical implication is that "steroid injection" is not a single evidence category a hospital can treat uniformly. A pain-management epidural programme and an orthopaedic joint-injection clinic are drawing on genuinely different bodies of evidence, even when the two departments order overlapping corticosteroid vials from the same pharmacy shelf.
Why does steroid injection stocking also matter for medical emergencies?
Beyond elective orthopaedic and pain-management use, injectable corticosteroids are a standard emergency-department and inpatient tool for acute severe asthma exacerbations, anaphylaxis as an adjunct after epinephrine, and acute inflammatory flares in multiple specialties. This emergency-use case has a fundamentally different stocking requirement than elective joint or epidural injections: it demands immediate, uninterrupted availability rather than scheduled procedural stock that can be ordered a day or two ahead.
A hospital pharmacy that treats all corticosteroid injection stock as one undifferentiated category risks under-provisioning the emergency-use formulations specifically, since elective procedural demand is more visible and easier to forecast than the unpredictable, time-critical emergency need sitting alongside it.
What is the regulatory and prescription status of injectable corticosteroids in India?
Injectable corticosteroids are Schedule H drugs under the Drugs and Cosmetics Rules, 1945, requiring a registered medical practitioner's prescription for sale, though they do not carry the additional NDPS-linked controls that apply to certain other prescription-only categories like benzodiazepines. This means the prescription-only barrier exists but the documentation burden at the pharmacy counter is the standard Schedule H requirement rather than a heavier psychotropic-substance protocol.
That comparatively lighter regulatory load is part of why this category is easy for a hospital pharmacy to under-manage: there's no external compliance pressure forcing tight formulary discipline the way there is for narcotic or psychotropic stock, so unless a hospital deliberately separates its emergency, procedural and specialty-specific corticosteroid stock, the distinctions described above can get lost in a single generic "steroids" bin.
What should a hospital pharmacy get right about stocking this category?
A hospital pharmacy needs three distinct steroid injection availability hospital pharmacy stocking lines: emergency-use formulations kept at a fixed minimum, procedural stock for scheduled epidural and joint-injection lists ordered against actual specialty demand, and awareness that repeat-dose joint injection protocols carry documented structural risk that should inform dispensing frequency.
Treating all three as one interchangeable inventory line invites exactly the kind of under-provisioning an emergency scenario cannot tolerate.
When a hospital's own pharmacy doesn't reliably distinguish and stock across these three use cases, a pain-management or orthopaedic list can get delayed waiting for procedural stock, or worse, emergency formulations can run short because procedural demand quietly consumed the shared shelf. A managed or in-house pharmacy that stocks against each specialty's actual, tracked demand rather than one blended corticosteroid category keeps both elective procedures and emergency response reliable, and keeps that volume of prescriptions and procedures inside the hospital rather than sending patients elsewhere. Medyzen's guides on managed hospital pharmacy services, prescription leakage and hospital revenue loss, and pharmacy inventory management for expiry and dead stock cover how to build this kind of differentiated stocking discipline.
Sources
- 1Transforaminal Epidural Steroid Injections: A Systematic Review and Meta-Analysis of Efficacy and Safety — PubMed, National Library of Medicine
- 2The Effect of Intra-articular Corticosteroids on Articular Cartilage: A Systematic Review — PubMed, National Library of Medicine
- 3Intra-articular corticosteroid injections increase the risk of requiring knee arthroplasty — PubMed, National Library of Medicine
- 4Epidural Steroids for Cervical and Lumbar Radicular Pain and Spinal Stenosis: Systematic Review Summary — PubMed, National Library of Medicine
- 5Central Drugs Standard Control Organisation — Drugs and Cosmetics Rules, 1945 — CDSCO, Government of India
This article is for informational purposes and is not a substitute for professional medical advice. Steroid injection choice, technique and frequency should be determined by a treating specialist based on individual clinical assessment.
FAQ
Frequently asked questions
For radicular pain from disc herniation specifically, yes: a systematic review found Level 1 evidence supporting transforaminal epidural steroid injections, with significant pain and function improvement at three and six months. Evidence for other indications like spinal stenosis or failed back surgery syndrome is considerably weaker.
No, they carry different documented risk profiles. Intra-articular injections show dose-dependent cartilage effects and a possible link to higher arthroplasty rates with repeated use, while transforaminal epidural injections are described as generally safe with rare but serious neurologic complications tied partly to technique and particulate steroid choice.
Yes, they are Schedule H drugs under the Drugs and Cosmetics Rules, 1945, requiring a registered medical practitioner's prescription for sale, though they do not carry the additional NDPS-linked controls applied to narcotics or certain psychotropic medicines.
Emergency use, in acute asthma or as an anaphylaxis adjunct, requires guaranteed, immediate availability, while procedural use for scheduled epidural or joint injections can be ordered against a forecastable specialty calendar. Treating both as one inventory line risks procedural demand quietly depleting stock a hospital needs to reserve for emergencies.
Yes. A systematic review of transforaminal epidural injections specifically identified an infraneural needle approach and blunt needles as offering the greatest safety margin, showing that procedural technique is a genuine safety variable alongside the corticosteroid formulation itself.
Dr. Ananya DeshpandeMBBS, DM (Endocrinology)
Consultant Endocrinologist
Dr. Ananya Deshpande is a consultant endocrinologist writing on diabetes and insulin therapy, thyroid disorders, GLP-1 agonists, and metabolic conditions.